GVK opens Ahmedabad clinical pharmacology unit

By Staff Reporter

- Last updated on GMT

Related tags Contract research organization Pharmacology

Indian CRO GVK Biosciences hopes new clinical pharmacology unit in Ahmedabad will help boost patient recruitment to meet growing demand for clinical trials in the region.

The 110 bed, three ward unit, which will focus on conducting early-stage safety trials in health volunteers, boosts existing local capacity and is in the ideal location according to contract research organization (CRO).

Ahmedabad was the most preferred and logical destination for expansion considering the volunteer pool accessibility and proximity to about 10 CROs and leading Pharma companies.”

Faster recruitment

GVK also said that, while a wide range of early-phase clinical trials will be carried out, one focus of the unit will be to increase the participation of women in research through the provision of dedicated “special housing facilities for female volunteers​.”

Company president Manni Kantipudi said: “The opening of the new GVK BIO Clinical Pharmacology unit reflects our commitment to offer faster recruitment solutions to our customers​,” and added that the first trial has already started.

Patient recruitment has been something of a focus for GVK so far in 2010, beginning in January when it became the latest member of the ResearchPoint Global Network (RGN)

At the time, Kantipudi explained that one of the benefits of the move was that the firm’s “existing clients will benefit from our ability to recruit patients across multiple geographies through RPG​.”

Ahmedabad good for trials

GVK is not the only CRO to be drawn to Ahmedabad in recent times. Earlier this month for example US firm Kendle unveiled plans to set up a major new facility in the region​.

Speaking to Outsourcing-pharma at the time Bharat Doshi, senior director of South-East Asia and India at Kendle, said that the large number of skilled researchers as well as the region’s status as a specialial economic zone were particularly attractive.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us